Table 1.
Comparison of demographic characteristics and clinical parameters between males and females
| Variable | Male (N=11) | Female (N=49) | Total (N=60) |
|---|---|---|---|
| Age [year], Mean (SD) | 42.73 (7.93) | 40.22 (8.14) | 40.94 (7.64) |
| Duration of therapy [month], Mean (SD) | 5.22 (2.43) | 6.31 (2.86) | 6.08 (2.54) |
| Anterior segment, N (%) | |||
| Normal | 9(81.8) | 42(85.7) | 51(85) |
| Abnormal | 2(18.2) | 7(14.3) | 9(15) |
| Posterior segment, N (%) | |||
| Normal | 9 (81.8) | 39 (79.6) | 48 (80) |
| Abnormal (with RPE) | 2 (18.2) | 10 (20.4) | 12 (20) |
| Hypertension, N (%) | 3 (27.3) | 15 (30.6) | 18 (30) |
| BMI [Kg/m2], Mean (SD) | 26.25 (4.09) | 24.43 (3.11) | 25.11 (3.64) |
| BCVA [logMAR], Mean (SD) | 0.17 (0.26) | 0.16 (0.31) | 0.16 (0.28) |
| Daily HCQ dose [mg], Mean (SD) | 161.8 (107.3) | 172.2 (95.3) | 168.6 (102.4) |
| Cumulative HCQ dose [g], Mean (SD) | 235.4 (175.4) | 241.5 (190.6) | 239.4 (182.1) |
BCVA: best corrected visual acuity; HCQ: hydroxychloroquine; logMAR: logarithm of the minimum angle of resolution scale; RPE: Retinal pigmented epithelium; mg: milligram; g: gram.